Vitt Daniel's Form 4/A amendment
AmendedImmunic, Inc. (IMUX) · filed Jun 20, 2025
- Accession no.
- 0001193805-25-000923
- Filed
- Jun 20, 2025
- Trade date
- Jun 4-5, 2025
- Filing delay
- 16 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 6, 2025
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $11.6K. It was filed 16 days after the trade.
This amendment replaces 0001193805-25-000821 (filed Jun 6, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vitt DanielCIK 0001773673 | Director, Officer (CEO and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | Common Stock | PPurchaseAcquired | +15,000 | $0.77F1 | +$11,550 | 29,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | Common Stock | AGrant or awardAcquired | +1,558,000 | $0.00 | $0 | 1,558,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
Referenced by the price of 1 transaction in Table I.
- F2
362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
- F3
25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.
Remarks
This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Peron on June 6, 2025 to correct an administrative error that incorrectly reported the number of stock options granted.